Bharti AC - Search Results

1

Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.

Bharti AC, Takada Y, Aggarwal BB. Bharti AC, et al. J Immunol. 2004 May 15;172(10):5940-7. doi: 10.4049/jimmunol.172.10.5940. J Immunol. 2004. PMID: 15128775

2

Induction of cell cycle arrest and apoptosis by the proteasome inhibitor PS-341 in Hodgkin disease cell lines is independent of inhibitor of nuclear factor-kappaB mutations or activation of the CD30, CD40, and RANK receptors.

Zheng B, Georgakis GV, Li Y, Bharti A, McConkey D, Aggarwal BB, Younes A. Zheng B, et al. Clin Cancer Res. 2004 May 1;10(9):3207-15. doi: 10.1158/1078-0432.ccr-03-0494. Clin Cancer Res. 2004. PMID: 15131062

3

Nuclear factor-kappa B and cancer: its role in prevention and therapy.

Bharti AC, Aggarwal BB. Bharti AC, et al. Biochem Pharmacol. 2002 Sep;64(5-6):883-8. doi: 10.1016/s0006-2952(02)01154-1. Biochem Pharmacol. 2002. PMID: 12213582 Review.

4

Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.

Bharti AC, Donato N, Singh S, Aggarwal BB. Bharti AC, et al. Blood. 2003 Feb 1;101(3):1053-62. doi: 10.1182/blood-2002-05-1320. Epub 2002 Sep 5. Blood. 2003. PMID: 12393461 Free article.

5

Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation.

Ashikawa K, Majumdar S, Banerjee S, Bharti AC, Shishodia S, Aggarwal BB. Ashikawa K, et al. Among authors: bharti ac. J Immunol. 2002 Dec 1;169(11):6490-7. doi: 10.4049/jimmunol.169.11.6490. J Immunol. 2002. PMID: 12444159

6

Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization.

Bharti AC, Aggarwal BB. Bharti AC, et al. Ann N Y Acad Sci. 2002 Nov;973:392-5. doi: 10.1111/j.1749-6632.2002.tb04671.x. Ann N Y Acad Sci. 2002. PMID: 12485899

7

Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells.

Bharti AC, Donato N, Aggarwal BB. Bharti AC, et al. J Immunol. 2003 Oct 1;171(7):3863-71. doi: 10.4049/jimmunol.171.7.3863. J Immunol. 2003. PMID: 14500688

8

Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism.

Bharti AC, Takada Y, Shishodia S, Aggarwal BB. Bharti AC, et al. J Biol Chem. 2004 Feb 13;279(7):6065-76. doi: 10.1074/jbc.M308062200. Epub 2003 Nov 25. J Biol Chem. 2004. PMID: 14645259 Free article.

9

Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis.

Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R, Raj-Vadhan S, Estrov Z, Talpaz M, Aggarwal BB. Bharti AC, et al. Blood. 2004 Apr 15;103(8):3175-84. doi: 10.1182/blood-2003-06-2151. Epub 2003 Dec 18. Blood. 2004. PMID: 15070700 Free article.

10

Ranking the role of RANK ligand in apoptosis.

Bharti AC, Aggarwal BB. Bharti AC, et al. Apoptosis. 2004 Nov;9(6):677-90. doi: 10.1023/B:APPT.0000045780.10463.c6. Apoptosis. 2004. PMID: 15505411 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters